Hyperostosis Corticalis Infantalis (Caffey's Disease)* J
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Soft Tissue Calcification and Ossification
Soft Tissue Calcification and Ossification Soft-tissue Calcification Metastatic Calcification =deposit of calcium salts in previously normal tissue (1) as a result of elevation of Ca x P product above 60-70 (2) with normal Ca x P product after renal transplant Location:lung (alveolar septa, bronchial wall, vessel wall), kidney, gastric mucosa, heart, peripheral vessels Cause: (a)Skeletal deossification 1.1° HPT 2.Ectopic HPT production (lung / kidney tumor) 3.Renal osteodystrophy + 2° HPT 4.Hypoparathyroidism (b)Massive bone destruction 1.Widespread bone metastases 2.Plasma cell myeloma 3.Leukemia Dystrophic Calcification (c)Increased intestinal absorption =in presence of normal serum Ca + P levels secondary to local electrolyte / enzyme alterations in areas of tissue injury 1.Hypervitaminosis D Cause: 2.Milk-alkali syndrome (a)Metabolic disorder without hypercalcemia 3.Excess ingestion / IV administration of calcium salts 1.Renal osteodystrophy with 2° HPT 4.Prolonged immobilization 2.Hypoparathyroidism 5.Sarcoidosis 3.Pseudohypoparathyroidism (d)Idiopathic hypercalcemia 4.Pseudopseudohypoparathyroidism 5.Gout 6.Pseudogout = chondrocalcinosis 7.Ochronosis = alkaptonuria 8.Diabetes mellitus (b) Connective tissue disorder 1.Scleroderma 2.Dermatomyositis 3.Systemic lupus erythematosus (c)Trauma 1.Neuropathic calcifications 2.Frostbite 3.Myositis ossificans progressiva 4.Calcific tendinitis / bursitis (d)Infestation 1.Cysticercosis Generalized Calcinosis 2.Dracunculosis (guinea worm) (a)Collagen vascular disorders 3.Loiasis 1.Scleroderma -
Osteochondrosis – Primary Epiphyseal (Articular/Subchondral) Lesion Can Heal Or Can Progress
60 120 180 1 distal humeral condyles 2 medial epicondyle 3 proximal radial epiphysis 4 anconeal process Lab Ret study N=1018 . Normal . Affected . Total 688 (67.6%) . Total 330 (32.4%) . Male 230 (62.2%) . Male 140 (37.8%) . Female 458 (70.7%) . Female 190 (29.3%) Affected dogs N=330 1affected site - 250 (75.7%) 2 affected sites - 68 (20.6%) 3 affected sites - 12 (3.6%) immature skeletal diseases denis novak technique for skeletal radiography tissue < 12 cm “non-grid” (“table-top”) technique “high detail” system radiation safety diagnosis X – rays examination Ultrasound CT bilateral lesions - clinical signs ? unilateral present > one type of lesion 2ry arthrosis Common Osteochondrosis – primary epiphyseal (articular/subchondral) lesion can heal or can progress Osteochondritis dissecans – free articular fragment will progress Arthrosis Osteochondrosis talus / tarsus Lumbosacral OCD Lumbosacral OCD Inflammatory diseases Panosteitis – non infectious Hypertrophic osteodystrophy (HOD) – perhaps infectious Osteomyelitis - infectious Panosteitis New medullary bone Polyostotic Multiple lesions in one bone Symmetrical or nonsymmetrical Sclerotic pattern B I L A T E R A L periosteal new bone forms with chronicity Cross sections of a tibia different locations Hypertrophic osteodystrophy (HOD) Dogs are systemically ill, febrile, anorectic, reluctant to walk most will recover Radiographic changes of HOD . Polyostotic . Metaphyseal . Symmetrical . Changes of lesion Early Mid Late lytic “plates” in acute case HOD - 4 m ret – lesions are present -
Injuries and Normal Variants of the Pediatric Knee
Revista Chilena de Radiología, año 2016. ARTÍCULO DE REVISIÓN Injuries and normal variants of the pediatric knee Cristián Padilla C.a,* , Cristián Quezada J.a,b, Nelson Flores N.a, Yorky Melipillán A.b and Tamara Ramírez P.b a. Imaging Center, Hospital Clínico Universidad de Chile, Santiago, Chile. b. Radiology Service, Hospital de Niños Roberto del Río, Santiago, Chile. Abstract: Knee pathology is a reason for consultation and a prevalent condition in children, which is why it is important to know both the normal variants as well as the most frequent pathologies. In this review a brief description is given of the main pathologies and normal variants that affect the knee in children, not only the main clinical characteristics but also the findings described in the different, most used imaging techniques (X-ray, ultrasound, computed tomography and magnetic resonance imaging [MRI]). Keywords: Knee; Paediatrics; Bone lesions. Introduction posteromedial distal femoral metaphysis, near the Pediatric knee imaging studies are used to evaluate insertion site of the medial twin muscle or adductor different conditions, whether traumatic, inflammatory, magnus1. It is a common finding on radiography and developmental or neoplastic. magnetic resonance imaging (MRI), incidental, with At a younger age the normal evolution of the more frequency between ages 10-15 years, although images during the skeletal development of the distal it can be present at any age until the physeal closure, femur, proximal tibia and proximal fibula should be after which it resolves1. In frontal radiography, it ap- known to avoid diagnostic errors. Older children and pears as a radiolucent, well circumscribed, cortical- adolescents present a higher frequency of traumatic based lesion with no associated soft tissue mass, with and athletic injuries. -
Chronic Non-Bacterial Osteomyelitis/Osteitis (Or CRMO) Version of 2016
https://www.printo.it/pediatric-rheumatology/IE/intro Chronic non-Bacterial Osteomyelitis/Osteitis (or CRMO) Version of 2016 1. WHAT IS CRMO 1.1 What is it? Chronic Recurrent Multifocal Osteomyelitis (CRMO) is the most severe form of Chronic Non-bacterial Osteomyelitis (CNO). In children and adolescents, the inflammatory lesions predominantly affect the metaphyses of the long bones of the lower limbs. However, lesions can occur at any site of the skeleton. Furthermore, other organs such as the skin, eyes, gastrointestinal tract and joints can be affected. 1.2 How common is it? The frequency of this disease has not been studied in detail. Based on data from European national registries, approximately 1-5 of 10,000 inhabitants might be affected. There is no gender predominance. 1.3 What are the causes of the disease? The causes are unknown. It is hypothesised that this disease is linked to a disturbance in the innate immune system. Rare diseases of bone metabolism might mimic CNO, such as hypophosphatasia, Camurati- Engelman syndrome, benign hyperostosis-pachydermoperiostosis and histiocytosis. 1.4 Is it inherited? 1 / 6 Inheritance has not been proven but is hypothesized. In fact, only a minority of cases is familial. 1.5 Why does my child have this disease? Can it be prevented? The causes are unknown to date. Preventive measures are unknown. 1.6 Is it contagious or infectious? No, it is not. In recent analyses, no causative infectious agent (such as bacteria) has been found. 1.7 What are the main symptoms? Patients usually complain of bone or joint pain; therefore, the differential diagnosis includes juvenile idiopathic arthritis and bacterial osteomyelitis. -
Tuberculosis of the Pubic Symphysis Masquerading As Osteitis Pubis: a Case Report
CASE REPORT Acta Orthop Traumatol Turc 2012;46(3):223-227 doi:10.3944/AOTT.2012.2696 Tuberculosis of the pubic symphysis masquerading as osteitis pubis: a case report Shailendra SINGH, Sumit ARORA, Sumit SURAL, Anil DHAL Department of Orthopedic Surgery, Maulana Azad Medical College & Associated Lok Nayak Hospital, New Delhi, India Tuberculosis is one of the oldest diseases affecting mankind and is known for its ability to present in various forms and guises. Pubic symphysis is an uncommon site for tuberculous affliction; hence very few cases have been reported in the English-language literature. We present a rare case of pubic sym- physis tuberculosis diagnosed as osteitis pubis before presentation to our institution. The patient made an uneventful recovery following antitubercular chemotherapy. Key words: Antitubercular chemotherapy; osteitis pubis; pubic symphysis; tuberculosis. Tuberculosis has been recorded in Egyptian mummies Case report aging back to 3000 B.C. It commonly affects the pul- A 35-year-old male presented with a history of supra- monary system but extrapulmonary involvement is pubic pain for six months following a fall while playing seen in approximately 14% of patients, with 1% to 8 % football. The pain was insidious in onset, dull aching in [1] having osseous involvement. The major areas of nature and localized in the suprapubic area. It predilection in order of occurrence are: spine, hip, increased on exertion and relieved with rest and anti- knee, foot, elbow and hand. Tuberculosis of the pubic inflammatory medications and was not aggravated by symphysis is rare and few cases have been presented in coughing, sneezing, voiding or straining during stool. -
Infantile Peri-Osteitis Postgrad Med J: First Published As 10.1136/Pgmj.74.871.307 on 1 May 1998
Self-assessment questions 307 Infantile peri-osteitis Postgrad Med J: first published as 10.1136/pgmj.74.871.307 on 1 May 1998. Downloaded from Alaric Aroojis, Harold D'Souza, M G Yagnik A 14-week-old girl was brought in with a history of painful swelling of both legs since the age of one month. The onset was insidious and was not associated with trauma or fall. There was no his- tory of fever or associated constitutional symp- toms. The birth history was normal and the infant was apparently asymptomatic until the age of one month. Examination revealed a healthy and alert infant. Both legs were bowed anteriorly and a uniform bony thickening of both tibiae was palpable throughout their lengths (figure 1). Both legs were extremely ten- der and the infant would withdraw both lower limbs and cry incessantly if any attempt was made to touch them. There was no increase in local temperature nor redness of the overlying skin. Knees and ankle joints were normal and demonstrated a full range of motion. Regional lymph nodes were not enlarged and other bones and joints were normal on examination. X-Rays of both legs revealed peri-osteitis of both tibiae with extensive subperiosteal new bone forma- tion involving the entire diaphysis (figure 2). Questions 1 What is the differential diagnosis of peri- osteitis in an infant? 2 What further investigations are required? Figure 1 Clinical photograph showing bony swelling 3 What is the likely diagnosis and treatment? with anterior bowing of both legs http://pmj.bmj.com/ on October 5, 2021 by guest. -
A Rare Manifestation of Primary Hyperparathyroidism Vikram Singh Shekhawat, Anil Bhansali
Images in… BMJ Case Reports: first published as 10.1136/bcr-2017-220676 on 1 August 2017. Downloaded from Vanishing metatarsal: a rare manifestation of primary hyperparathyroidism Vikram Singh Shekhawat, Anil Bhansali Department of Endocrinology, DESCRIPTION Post Graduate Institute A 31-year-old woman presented with a history of Medical Education and of bone pains, difficulty in walking and painless Research, Chandigarh, India swelling of the left foot for the last 1 year (figure 1). X-ray of the left foot showed multiple lytic lesions Correspondence to Dr Anil Bhansali, in metatarsal bones and the absence of proximal anilbhansa lien docr ine@ gma il. half of shaft of second metatarsal. Biochemistry com, ashuendo@ gmail. com results revealed corrected serum calcium 11.2 mg/ dL, phosphate 2.0 mg/dL, alkaline phosphatase Accepted 25 July 2017 1049 IU/mL, intact parathyroid hormone (iPTH) 2543 pg/mL, 25-hydroxyvitamin D 16.2 ng/mL, and serum creatinine 0.6 mg/dL. She had no history of pancreatitis or evidence of renal/gall stone disease. The skeletal survey showed multiple osteitis fibrosa cystica (OFC) lesions, pathological Figure 2 (A) X–ray of both foot showing generalised fracture of shaft of the left femur and salt and demineralization of foot bones, multiple lytic lesions pepper appearance of the skull (figure 2a, b, c). (brown tumours) and apparent disappearance of proximal Sestamibi scan revealed right inferior parathyroid half of second metatarsal of the left foot. (B) X–ray of adenoma measuring 3.0×2.9×2.2 cm. Based on pelvis showing ill-defined lucencies in bilateral iliac, pubic the above findings, a diagnosis of primary hyper- and ischial bones, and pathological fracture of left femur. -
Relapsing Polychondritis – Analysis of Symptoms and Criteria
Original paper Reumatologia 2019; 57, 1: 8–18 DOI: https://doi.org/10.5114/reum.2019.83234 Relapsing polychondritis – analysis of symptoms and criteria Beata Maciążek-Chyra1, Magdalena Szmyrka1,2, Marta Skoczyńska1,2, Renata Sokolik1,2, Joanna Lasocka2, Piotr Wiland1,2 1Clinic of Rheumatology and Internal Medicine, Wrocław University Hospital, Poland 2Department and Clinic of Rheumatology and Internal Medicine, Wrocław Medical University, Poland Abstract Objectives: Relapsing polychondritis (RP) is a rare disease characterised by recurrent inflammation of the cartilaginous structures and proteoglycan-rich organs. The aim of this case series study is to share the 10-year clinical experience of our department in diagnosing RP patients in the context of data from available published studies. Material and methods: A retrospective case analysis of 10 patients with symptoms of RP, hospi- talised at the Department of Rheumatology and Internal Diseases of Wrocław University Hospital between January 2008 and December 2018. Results: Nine out of 10 patients fulfilled at least one of the three sets of the diagnostic criteria. The mean age (±standard deviation) at diagnosis was 54.4 ±13.3 years and ranged from 32 to 73 years. The symptoms suggestive of the RP diagnosis were mainly inflammation of the pinna (in 80% of patients) and laryngeal stenosis (in 20% of patients). The mean age at which initial symptoms were observed was 52.3 ±12.0 years and ranged from 31 to 69 years. Auricular chondritis was the first mani- festation of the disease in 40% of cases (two women and two men) laryngeal chondritis in 20%, nasal chondritis in 10%, and bronchial stenosis in 10%. -
Clinical and Laboratory Considerations in Metabolic Bone Disease
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 5, No. 4 Copyright ® 1975, Institute for Clinical Science Clinical and Laboratory Considerations in Metabolic Bone Disease LYNWOOD H. SMITH, M.D. AND B. LAWRENCE RIGGS, M.D. Mayo Clinic and Mfiyo Foundation Rochester, MN 55901 ABSTRACT An overview of the common types of metabolic bone disease is described. When the disease is present in pure form, diagnosis is not difficult. When mixed disease is present, as may be the case, the pathophysiology involved must be clearly under stood for accurate diagnosis and treatment. Introduction opausal or senile osteoporosis, a disorder of unknown etiology, is the commonest form of There are many metabolic disorders that bone disease in the Western hemisphere. affect human bones; but, fortunately, the This disorder may simply represent an exag ways in which bones can respond are limited geration of the normal loss of bone that oc so that certain generalizations are valid for a curs with aging. It is estimated that the total group of diseases causing a characteristic bone loss between youth and old age is metabolic abnormality in the bone. The about 35 percent in women and somewhat common pathologic responses to metabolic less in men. The loss of bone that has oc bone disease include osteoporosis, os curred in some patients with osteoporosis is teomalacia, Paget’s disease, osteitis fibrosa not significantly different from that in age- cystica and renal osteodystrophy. These are matched normals without osteoporosis. not mutually exclusive, and it is not uncom In osteoporosis there is a greater propor mon to find more than one abnormality in tional loss of trabecular than of cortical the same patient. -
Melorheostosis, a Rare Disease That Causes Chronic Pain: Efficacy of Pulsed Radiofrequency
Open Access Austin Journal of Anesthesia and Analgesia Case Report Melorheostosis, A Rare Disease That Causes Chronic Pain: Efficacy of Pulsed Radiofrequency Rodríguez-Navarro MA*, Alcaraz AB, Benitez M, Mula-Leal J, Padilla-Del Rey ML, Díaz C and Abstract Castillo JA Melorheostosis is an exceptionally rare sclerosing hyperostosis. Recent Department of Anenesthesia and Pain Management, studies of melorheostosis indicate that most cases arise from somatic MAP2K1 General University Hospital, José María Morales mutations, those cases are more likely to have the classic “dripping candle Meseguer, Murcia, Spain wax” appearance on radiographs. It has an incidence of 0.9 cases per million *Corresponding author: Maria Angeles Rodríguez inhabitants and it is distributed equally between both sexes. Navarro, Department of Anenesthesia and Pain Why Melorheostosis is a syndrome that pain physician need to know? The Management, General University Hospital, José María presenting features of melorheostosis are variable, depending on the site and Morales Meseguer, Murcia, Spain extent of the bone disease and whether there is any associated soft tissue Received: May 27, 2020; Accepted: June 16, 2020; involvement. Some cases are identified from incidental radiographic findings, Published: June 23, 2020 but the most common syndrome there will be chronic pain. Despite this, there is no any publication in “pain management journals”. In addition to drug treatment, which is in constant revision, we propose to apply Pulsed Radiofrequency of the nerves (PRF) to treat pain in melorheostosis based in the efficacy published. We reported a case of 39-year-old male suffering 15 years of chronic hip pain because of Melorheostosis. The results of PRF of articular branches of femoral and obturator nerves have been very successful. -
Maize and Bone: an Evaluation and Expansion of a Proposed Model for the Differential Diagnosis of Pellagra in Human Remains
The University of Southern Mississippi The Aquila Digital Community Master's Theses Spring 2019 Maize and Bone: An Evaluation and Expansion of a Proposed Model for the Differential Diagnosis of Pellagra in Human Remains Myra G. Miller University of Southern Mississippi Follow this and additional works at: https://aquila.usm.edu/masters_theses Part of the Biological and Physical Anthropology Commons Recommended Citation Miller, Myra G., "Maize and Bone: An Evaluation and Expansion of a Proposed Model for the Differential Diagnosis of Pellagra in Human Remains" (2019). Master's Theses. 639. https://aquila.usm.edu/masters_theses/639 This Masters Thesis is brought to you for free and open access by The Aquila Digital Community. It has been accepted for inclusion in Master's Theses by an authorized administrator of The Aquila Digital Community. For more information, please contact [email protected]. MAIZE AND BONE: AN EVALUATION AND EXPANSION OF A PROPOSED MODEL FOR THE DIFFERENTIAL DIAGNOSIS OF PELLAGRA IN HUMAN REMAINS by Myra Gale Miller A Thesis Submitted to the Graduate School, the College of Arts and Sciences and the School of Social Science and Global Studies at The University of Southern Mississippi in Partial Fulfillment of the Requirements for the Degree of Master of Arts Approved by: Dr. Marie Danforth, Committee Chair Dr. H. Edwin Jackson Dr. B. Katherine Smith Dr. Andrew P. Haley ____________________ ____________________ ____________________ Dr. Marie Danforth Dr. Edward Sayre Dr. Karen S. Coats Committee Chair Director of School Dean of the Graduate School May 2019 COPYRIGHT BY Myra G. Miller 2019 Published by the Graduate School ABSTRACT This study attempts to test and expand a previous study to establish a differential diagnosis of pellagra in human remains (Paine & Brenton, 2006a). -
Zoledronic Acid
Zoledronic acid (Zometa®, Reclast®) (Intravenous) Document Number: IC‐0153 Last Review Date: 07/03/2019 Date of Origin: 06/21/2011 Dates Reviewed: 09/2011, 12/2011, 03/2012, 06/2012, 09/2012, 12/2012, 03/2013, 06/2013, 09/2013, 12/2013, 03/2014, 06/2014, 09/2014, 12/2014, 03/2015, 05/2015, 08/2015, 11/2015, 02/2016, 05/2016, 08/2016, 11/2016, 01/2017, 05/2017, 08/2017, 07/2018, 07/2019 I. Length of Authorization Zometa: Coverage is provided for 12 months and may be renewed. Reclast: Prevention of osteoporosis in post-menopausal women: Coverage is provided for 24 months and may be renewed. All other indications: Coverage is provided for 12 months and may be renewed (unless otherwise specified). II. Dosing Limits A. Quantity Limit (max daily dose) [Pharmacy Benefit]: Zometa Indication Quantity Limit Hypercalcemia of malignancy 4 mg bottle/vial per 7 days Multiple myeloma & bone metastases from 4 mg bottle/vial every 21 days solid tumors Prevention of bone loss in breast cancer 4 mg bottle/vial every 168 days (6 months) Prevention of bone loss in prostate cancer & 4 mg bottle/vial every 84 days (3 months) Prevention or treatment of osteoporosis in prostate cancer Reclast Indication Quantity Limit Proprietary & Confidential © 2019 Magellan Health, Inc. Prevention of osteoporosis in post- 5 mg solution every 730 days (24 months) menopausal women All other indications 5 mg solution every 365 days (12 months) B. Max Units (per dose and over time) [Medical Benefit]: Zometa Indication Max Units Hypercalcemia of malignancy 4 billable units per 7 days Multiple myeloma & bone metastases from 4 billable units every 21 days solid tumors Prevention of bone loss in breast cancer 4 billable units every 168 days (6 months) Prevention of bone loss in prostate cancer & 4 billable units every 84 days (3 months) Prevention or treatment of osteoporosis in prostate cancer Reclast Indication Max Units Prevention of osteoporosis in post- 5 billable units every 730 days (24 months) menopausal women All other indications 5 billable units every 365 days (12 months) III.